Skip to main content
Caplight Logo









IncreBio

IncreBio

Private
BangkokHealthcare & Life Scienceshttp://incre.bio

Last Round

Seed

Nov 1, 2023

Total Funding Raised

$1.5M

Company Overview

IncreBio is a food biotechnology company developing food and beverage products using biology. The company has developed a proprietary biotechnology solution that enables the production of juices with significantly lower sugar content.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

sugar reduction technologyfood biotechfermentation technologyfood techlow sugar juicemicrobial fermentationB2B food technologyfood ingredient supplierfood formulationhealthy beverageCPG brandnon-GMONutri-Grade complianceketo friendly foodD2C brand

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IncreBio Comparables

Compare IncreBio with similar companies based on industry and business-model similarity.

IncreBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BlueTree Technologies
78%
Prodalim
78%
Oobli
63%

IncreBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2023
Pre SeedFeb 27, 2019

IncreBio Investors

Notable investors and investment history

IncreBio investors
InvestorRounds
500 Southeast AsiaPre Seed
500 GlobalVC Round, Pre Seed
TOP VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2023

    $500K raised from Archawat Chareonsilp and Ramade Silapapom.

  • Feb 27, 2019

    $500K round led by 500 Global

IncreBio Filings

Explore SEC and related filing metadata, where available.

IncreBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IncreBio's valuation, stock price, and market status.

Is IncreBio a public or private company?

IncreBio is a private company.

What is the current stock price of IncreBio?

IncreBio is a private company with no public stock price. No recent secondary market data is available.

How much is IncreBio worth (valuation)?

Valuation information for IncreBio is not publicly available.

Can I buy IncreBio stock?

IncreBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IncreBio's last funding round?

IncreBio's most recent funding round was Seed on November 1, 2023.

Who are the main investors in IncreBio?

Key investors in IncreBio include 500 Southeast Asia, 500 Global, TOP Ventures.

Will IncreBio IPO soon?

No public IPO plans have been announced for IncreBio.

How can I track IncreBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IncreBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangkok
Year Founded2014
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?